Torben Lund-Hansen - Jan 26, 2023 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role: SVP & CHIEF TECHNICAL OFFICER
Signature: /s/ Sune Reinholth Nyland, Attorney-in-Fact for Torben Lund-Hansen
Stock symbol: YMAB
Transactions as of: Jan 26, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/30/2023, 03:34 PM
Previous filing: Jan 19, 2023
Next filing: Jan 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	YMAB	Employee Stock Option (right to buy)	Award	$0	+32K		$0.00	32K	Jan 26, 2023	Common stock	32K	$4.55	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
F2	The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 26, 2024, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting.

Remarks:

Exhibit Index: Exhibit 24 - Power of Attorney for Torben Lund-Hansen dated December 5, 2022.